Health condition
Nephrogenic systemic fibrosis: what to know
Nephrogenic systemic fibrosis (NSF) is a rare, disabling scarring disorder of skin and deeper tissues seen almost exclusively in people with severe kidney failure exposed to certain older gadolinium MRI contrast agents; modern contrast policies have made new cases exceptionally rare.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Progressive thickening, hardening and darkening of the skin of the limbs, with pain, itch and joint contractures; the face is characteristically spared
-
Occurs almost only in advanced kidney disease (dialysis or eGFR under 15) after exposure to older "linear" gadolinium-based contrast agents
-
Onset ranges from days to months after exposure; skin biopsy supports the diagnosis
-
Prevention has transformed the picture: high-risk linear agents are restricted, and newer macrocyclic agents carry an extremely low risk
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
NSF was recognised in the early 2000s when dialysis patients began developing woody, contracting skin on the legs and arms after MRI scans; the retained gadolinium, unable to be cleared by failing kidneys, triggered fibrosis that could extend into muscle and around joints, sometimes costing patients the ability to walk. It remains a cautionary tale in drug safety - and the reason kidney function is checked before contrast MRI.
Diagnosis and treatment routes
For the small number of people living with established NSF, care is multidisciplinary: intensive physiotherapy to limit contractures, analgesia, and case-report-level treatments including UVA1 phototherapy, extracorporeal photopheresis and imatinib, with restoration of kidney function via transplantation associated with the best chance of improvement. Anyone with kidney failure needing enhanced MRI today can be reassured that current UK protocols use low-risk macrocyclic agents at the minimum effective dose. In much of the UK, a routine NHS referral to the relevant specialist clinic can take several months, whereas an initial appointment with a private consultant is typically available within around two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a dermatologist and renal team. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Nephrogenic systemic fibrosis: what to know.
Quick, plain-English answers to what people ask us most.
-
What is nephrogenic systemic fibrosis?
Nephrogenic systemic fibrosis is a rare, serious condition causing progressive thickening and hardening of the skin and connective tissue, historically linked to exposure to certain gadolinium-based contrast agents used in MRI scans in people with significant kidney impairment.
-
What causes nephrogenic systemic fibrosis?
It's caused by retention of certain older, less stable gadolinium contrast agents in people with significantly reduced kidney function, who cannot clear the contrast agent from the body normally.
-
What are the symptoms of nephrogenic systemic fibrosis?
Symptoms include progressive skin thickening and tightening, typically affecting the limbs, sometimes with joint stiffness and, in severe cases, involvement of internal organs, developing over days to weeks after the triggering exposure.
-
Is nephrogenic systemic fibrosis dangerous?
Yes, it can cause significant, sometimes disabling, skin and joint stiffness, and in rare severe cases, involvement of internal organs can be life-threatening, though it's now much rarer due to safer contrast agent protocols.
-
How is nephrogenic systemic fibrosis prevented today?
Prevention relies on careful screening of kidney function before MRI contrast is given, avoiding higher-risk contrast agents in people with significant kidney impairment, and using the lowest effective contrast dose, which has made new cases very rare.
-
Can nephrogenic systemic fibrosis be treated?
Treatment is difficult once established, and there's no reliably effective cure, though some improvement in kidney function, physiotherapy, and various medical treatments have shown some benefit in individual cases.
-
When should I discuss contrast MRI risk if I have kidney disease, and how quickly can specialist advice be arranged privately?
Discuss this with your doctor before any MRI with contrast if you have significant kidney impairment. A private nephrologist or radiologist can typically provide advice on safer imaging options within about one to two weeks.